Bo Hu

10.5k total citations · 2 hit papers
118 papers, 6.7k citations indexed

About

Bo Hu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Bo Hu has authored 118 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Molecular Biology, 42 papers in Cancer Research and 35 papers in Oncology. Recurrent topics in Bo Hu's work include Hepatocellular Carcinoma Treatment and Prognosis (15 papers), Cancer-related molecular mechanisms research (14 papers) and MicroRNA in disease regulation (12 papers). Bo Hu is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (15 papers), Cancer-related molecular mechanisms research (14 papers) and MicroRNA in disease regulation (12 papers). Bo Hu collaborates with scholars based in China, United States and Ethiopia. Bo Hu's co-authors include Jia Fan, Xin‐Rong Yang, Yun‐Fan Sun, Jian Zhou, Yang Xu, Wei Guo, Shuang–Jian Qiu, Richard A. Flavell, Xin Zhang and Chao Sun and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Bo Hu

111 papers receiving 6.7k citations

Hit Papers

Systemic Immune-Inflammation Index Predicts Prognosis of ... 2012 2026 2016 2021 2014 2012 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Systemic Immune-Inflammation Index Predicts Prognosis of Patients after Curative Resection for Hepatocellular Carcinoma
    2014 1.6k citations Bo Hu, Xin‐Rong Yang et al. Clinical Cancer Research profile →
  2. IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine
    2012 583 citations Samuel Huber, Bo Hu et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bo Hu China 38 2.9k 2.5k 1.7k 1.5k 877 118 6.7k
Martina Müller Germany 33 3.1k 1.1× 1.7k 0.7× 818 0.5× 1.0k 0.7× 450 0.5× 140 5.9k
Shabnam Shalapour United States 26 2.8k 1.0× 1.7k 0.7× 975 0.6× 2.0k 1.3× 502 0.6× 40 6.0k
Beicheng Sun China 50 4.7k 1.6× 1.9k 0.8× 3.0k 1.8× 1.7k 1.1× 611 0.7× 177 8.7k
Hai Huang China 46 2.8k 1.0× 1.1k 0.4× 1.1k 0.6× 2.8k 1.8× 545 0.6× 156 7.3k
Joji Kitayama Japan 49 2.9k 1.0× 2.7k 1.1× 1.4k 0.8× 857 0.6× 1.1k 1.2× 195 7.4k
Jian Huang China 47 3.1k 1.0× 2.3k 0.9× 2.0k 1.1× 1.8k 1.2× 765 0.9× 242 7.0k
Bo Zhu China 47 2.9k 1.0× 3.3k 1.3× 1.6k 0.9× 2.7k 1.7× 1.6k 1.8× 213 7.9k
Hein W. Verspaget Netherlands 53 3.1k 1.1× 2.1k 0.8× 1.7k 1.0× 1.6k 1.1× 681 0.8× 236 9.7k
Kellie A. Charles Australia 27 1.8k 0.6× 4.8k 1.9× 1.7k 1.0× 2.9k 1.9× 1.0k 1.2× 44 8.3k

Countries citing papers authored by Bo Hu

Since Specialization
Citations

This map shows the geographic impact of Bo Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Hu more than expected).

Fields of papers citing papers by Bo Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bo Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Hu. The network helps show where Bo Hu may publish in the future.

Co-authorship network of co-authors of Bo Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Bo Hu. A scholar is included among the top collaborators of Bo Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bo Hu. Bo Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tian, He, Ziyi Wang, Xiaodong Zhu, et al.. (2025). The prognostic value of systemic immune-inflammation index in patients with unresectable hepatocellular carcinoma treated with immune-based therapy. Biomarker Research. 13(1). 10–10. 4 indexed citations
2.
3.
Wu, Suiyi, Yuanyuan Zhu, Jialei Sun, et al.. (2025). Targeting tumor-intrinsic BCL9 reverses immunotherapy resistance by eliciting macrophage-mediated phagocytosis and antigen presentation. Nature Communications. 16(1). 10039–10039. 1 indexed citations
4.
Guan, Ruo‐Yu, Zhangfu Yang, Bao‐Ye Sun, et al.. (2024). Effective Antiviral Therapy Improves Immunosuppressive Activities in the Immune Microenvironment of Hepatocellular Carcinoma by Alleviating Inflammation and Fibrosis. Cancer Medicine. 13(23). e70459–e70459. 1 indexed citations
5.
Jin, Anli, Chunyan Zhang, Wenjing Zheng, et al.. (2022). CD155/SRC complex promotes hepatocellular carcinoma progression via inhibiting the p38 MAPK signalling pathway and correlates with poor prognosis. Clinical and Translational Medicine. 12(4). e794–e794. 26 indexed citations
6.
Hu, Bo, Xiaolu Ma, Pei‐Yao Fu, et al.. (2021). The mRNA–miRNA–lncRNA Regulatory Network and Factors Associated with Prognosis Prediction of Hepatocellular Carcinoma. Genomics Proteomics & Bioinformatics. 19(6). 913–925. 20 indexed citations
7.
Yang, Wenjing, Yun‐Fan Sun, Anli Jin, et al.. (2020). BCL11B suppresses tumor progression and stem cell traits in hepatocellular carcinoma by restoring p53 signaling activity. Cell Death and Disease. 11(10). 895–895. 15 indexed citations
8.
Zhang, Jun, et al.. (2020). <p>KLF16 Affects the MYC Signature and Tumor Growth in Prostate Cancer</p>. OncoTargets and Therapy. Volume 13. 1303–1310. 15 indexed citations
9.
Song, Fei, Bo Hu, Jianwen Cheng, et al.. (2020). Anlotinib suppresses tumor progression via blocking the VEGFR2/PI3K/AKT cascade in intrahepatic cholangiocarcinoma. Cell Death and Disease. 11(7). 573–573. 87 indexed citations
10.
11.
Fu, Pei‐Yao, Bo Hu, Xiaolu Ma, et al.. (2019). Far upstream element-binding protein 1 facilitates hepatocellular carcinoma invasion and metastasis. Carcinogenesis. 41(7). 950–960. 13 indexed citations
12.
Wang, Wei, Jianwen Cheng, Jiang‐Jiang Qin, et al.. (2019). MDM2-NFAT1 dual inhibitor, MA242: Effective against hepatocellular carcinoma, independent of p53. Cancer Letters. 459. 156–167. 38 indexed citations
13.
He, Jia, Qiaozhu Zuo, Bo Hu, et al.. (2019). A novel, liver-specific long noncoding RNA LINC01093 suppresses HCC progression by interaction with IGF2BP1 to facilitate decay of GLI1 mRNA. Cancer Letters. 450. 98–109. 98 indexed citations
14.
Fu, Pei‐Yao, Bo Hu, Xiaolu Ma, et al.. (2018). New insight into BIRC3: A novel prognostic indicator and a potential therapeutic target for liver cancer. Journal of Cellular Biochemistry. 120(4). 6035–6045. 34 indexed citations
15.
16.
Zhang, Jun, Xilong Wang, Yangyun Wang, et al.. (2017). Low expression of microRNA-30c promotes prostate cancer cells invasion involved in downregulation of KRAS protein. Oncology Letters. 14(1). 363–368. 14 indexed citations
17.
Guo, Wei, Xin‐Rong Yang, Yun‐Fan Sun, et al.. (2014). Clinical Significance of EpCAM mRNA-Positive Circulating Tumor Cells in Hepatocellular Carcinoma by an Optimized Negative Enrichment and qRT-PCR–Based Platform. Clinical Cancer Research. 20(18). 4794–4805. 98 indexed citations
18.
Hu, Bo, Xin‐Rong Yang, Yang Xu, et al.. (2014). Systemic Immune-Inflammation Index Predicts Prognosis of Patients after Curative Resection for Hepatocellular Carcinoma. Clinical Cancer Research. 20(23). 6212–6222. 1558 indexed citations breakdown →
19.
Hu, Bo, Eran Elinav, Samuel Huber, et al.. (2010). Inflammation-induced tumorigenesis in the colon is regulated by caspase-1 and NLRC4. Proceedings of the National Academy of Sciences. 107(50). 21635–21640. 383 indexed citations
20.
Li, Xiaohong, et al.. (2007). [Effect of lysis of acupotomology on plasma vasoactive substance levels in rats with third lumbar vertebra transverse process syndrome].. PubMed. 32(5). 323–6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Martina Müller Breakdown of academic impact, for papers by Shabnam Shalapour Breakdown of academic impact, for papers by Beicheng Sun Breakdown of academic impact, for papers by Hai Huang Breakdown of academic impact, for papers by Joji Kitayama Breakdown of academic impact, for papers by Jian Huang Breakdown of academic impact, for papers by Bo Zhu Breakdown of academic impact, for papers by Hein W. Verspaget Breakdown of academic impact, for papers by Kellie A. Charles
Rankless by CCL
2026